The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent ...

The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...

Italian authorities have arrested a Chinese man accused by US prosecutors of being part of a hacking team that stole coveted ...

Medical associations representing hundreds of thousands of doctors, medical professionals and scientists in the United States ...

A new Covid-19 variant, officially known as NB.1.8.1 and nicknamed Nimbus, is now the most common strain in the US, according ...

The American Academy of Pediatrics and the Society for Maternal-Fetal Medicine, among other medical groups, joined the ...

South Africa’s health ministry has expressed concern about a persistent campaign of Covid-19 vaccine disinformation ...

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...